entertainment -WSS

entertainment

author：leisure time 2025-08-26 10:54:39 - browse：73

-- health tech coverage from STAT — Courtesy Xaia/Cedars-Sinai

Apple Vision Pro, the company’s most important new product in a decade, promises to envelop consumers in an immersive world of interactive content while employing clever technologies to make the device more usable and less alienating than virtual reality headsets that have come before it.

Marketing for Vision Pro has focused on the $3,499, 1.3-pound helmet’s potential for watching video, making work calls, viewing family photos, and other casual uses. But as with its other devices, Apple is eager to explore Vision Pro’s health potential as well. The company connected STAT with researchers from Cedars-Sinai and Boston Children’s Hospital who have developed applications that transform the headset into an AI powered chatbot that offers otherworldly therapy sessions or a virtual guide that can train nurses by simulating the chaos of a busy hospital.

VRx Health, founded by researchers from Cedars-Sinai in Los Angeles, is today launching Xaia, a mental health chatbot app that uses an artificial intelligence model to generate human-like responses to users’ statements. A therapeutic chatbot isn’t a new idea, but Xaia takes advantage of Vision Pro’s ability to convincingly blend digital content with an image of the world around users.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Medicare Advantage enrollment hits roughly 33.4 million

WSS

Biden's order seeks to regulate AI risk without stifling innovation

Testing for cancer recurrence creates a new limbo for patients

FDA has safety concerns on CRISPR

Opioid cravings were reduced by anti

Weight loss drugs aren’t covered by Obamacare. That may change

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

entertainment

entertainment

entertainment

How one medical school became remarkably diverse

Testing for cancer recurrence creates a new limbo for patients

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

At least 13 dead in Texas as scorching temps continue

In 'major milestone,' FDA approves first cell therapy for solid tumors

What does generative AI mean for health care? We asked experts

Medtronic CEO on promising devices for diabetes, hypertension

DIEP, the 'gold standard' of breast reconstruction, is under threat

Cassava reveals details — and problems — with Alzheimer's study

focus

Flagship Pioneering startup Sonata Therapeutics lays off 21

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Medtronic CEO on promising devices for diabetes, hypertension

Researchers tackle phage therapy hurdles for wider adoption

Medicare Advantage enrollment grows 7.1% to 33.4 million people

focus

focus

Wikipedia

explore